Clinical trial
Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
NCT03432234
Study timeline
Study start (actual)2016-03-07Date precision: day
Registry last updated2020-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Exacerbation COPDunresolved
Interventions
BiomarkersOTHER
Sponsors & collaborators
Corporacion Parc Taulilead sponsor
Hospital de Sant Paucollaborator
Hospital Clinic of Barcelonacollaborator
Hospital Universitari de Bellvitgecollaborator
Hospital del Marcollaborator
Germans Trias i Pujol Hospitalcollaborator
Hospital Arnau de Vilanovacollaborator
Centre for Genomic Regulationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03432234 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.